U.S. Construction Stock News

Applied Industrial Technologies (AIT) has been in focus after acquiring Thompson Industrial Supply. This event is expected to add meaningful annual revenue, while the core Service Center distribution segment reports steady demand and organic sales growth. See our latest analysis for Applied Industrial Technologies. While the share price has eased slightly in the past month, with a 30 day share price return of a 2.85% decline, the 1 year total shareholder return of 27.62% and 5 year total...

In March 2026, Beyond Meat reported fourth-quarter 2025 results showing sales falling to US$61.59 million from US$76.66 million a year earlier, while a shift to net income of US$409.85 million and guidance for first-quarter 2026 revenues of US$57 million to US$59 million highlighted weaker demand and softer near‑term expectations. The company also disclosed material weaknesses in inventory accounting, delaying its annual filing and adding governance and reliability concerns to already...

Why Trane Technologies Stock Is Back on Investors’ Radar Trane Technologies (TT) is back in focus after its latest quarterly report topped revenue and earnings expectations, paired with upbeat 2026 guidance on organic growth and adjusted earnings per share. See our latest analysis for Trane Technologies. The share price has eased 2.1% over the past month but remains supported by a 7.3% 90 day share price return and a 35.5% 1 year total shareholder return. This suggests momentum is still...

PENN Entertainment (PENN) moved following a broader market rally tied to potential de-escalation in Iran and more reassuring Federal Reserve comments on interest rates, raising questions about how much of the stock reaction is company specific. See our latest analysis for PENN Entertainment. That move sits within a mixed recent pattern, with a 7-day share price return of 7.26% but a 30-day share price return of 4.52% and a 1-year total shareholder return of 3.36%. Longer term performance,...

Short term gains and longer term picture for Weis Markets Weis Markets (WMK) has drawn fresh attention after recent share price moves, with the stock showing positive returns over the past week, month and past 3 months while longer term performance looks more mixed. See our latest analysis for Weis Markets. The recent 1 month share price return of 9.9% and 3 month share price return of 9.6% suggest momentum has picked up in the short term, even though the 1 year total shareholder return of...

In late March 2026, HP Inc. unveiled a broad lineup of AI-enabled EliteBook and Z workstations, HP IQ on-device intelligence, NearSense connectivity, Wolf Security upgrades, TPM Guard, and quantum-resistant LaserJet printers, targeting productivity, security, and hybrid-work needs across PCs, printers, and gaming systems. A particularly distinctive element is HP TPM Guard, which encrypts the TPM-to-CPU link to block low-cost physical attacks that can bypass BitLocker, while HP also moves to...

EPAM Systems: Investor attention after Nordic recognition and AI focus EPAM Systems (EPAM) has drawn fresh investor attention after being ranked the leading IT services provider in the Nordics and detailing its AI and security services plans at its 2026 Investor Day. See our latest analysis for EPAM Systems. Despite the recent recognition in the Nordics and its AI focused Investor Day, EPAM’s share price return tells a mixed story, with a 1 day gain of 2.12% but a 90 day share price return...

Century Communities (CCS) has been busy adding new communities across Texas, California, Colorado, Kentucky, Arizona, Georgia, and South Carolina. The company is pairing hundreds of new homesites with smart-home features and an online homebuying platform. See our latest analysis for Century Communities. Despite a steady stream of new community launches and an expanded multi state footprint, Century Communities' recent share price has been choppy, with a 7 day share price return of 2.74% set...

Pharvaris N.V. recently reported full-year 2025 results showing a net loss of €175.7 million, with basic and diluted loss per share from continuing operations of €2.97, while advancing its hereditary angioedema (HAE) pipeline. Despite deeper losses, Pharvaris completed enrollment in its CHAPTER-3 pivotal study of deucrictibant XR and stayed on track for a near-term regulatory filing for deucrictibant IR, underscoring the company’s focus on progressing multiple HAE treatment approaches. We’ll...

In late March 2026, Intercontinental Exchange, Inc. completed a combined US$1.60 billion cash investment in Polymarket, secured exclusive rights to distribute its event-driven data globally, and through NYSE partnered with Securitize to build an on-chain tokenized securities settlement platform. This move highlights ICE’s push to layer alternative, event-based data and blockchain-enabled settlement on top of its existing market infrastructure, potentially reshaping how institutional clients...

Geopolitics and recent price swings Murphy Oil (MUR) has been moving in step with oil market swings tied to the U.S. Iran conflict, with rising tensions lifting the share price and later de escalation headlines reversing part of that move. See our latest analysis for Murphy Oil. Beyond the latest geopolitical swings, Murphy Oil’s 1 month share price return of 19.87% and year to date gain of 26.44% sit alongside a very large 5 year total shareholder return of 193.69%, suggesting momentum that...

Recent performance and context for Louisiana-Pacific Louisiana-Pacific (LPX) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. At a recent close of US$70.81 and a market value of about US$4.9b, the company sits against a backdrop of reported annual revenue of US$2,708.0 million and net income of US$146.0 million. See our latest analysis for Louisiana-Pacific. The...

In recent weeks, Strategy Inc. paused its 13‑week Bitcoin accumulation streak, kept the monthly dividend on its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) steady at 11.5%, and its board declared a US$0.96 cash dividend per STRC share for April, payable on April 30, 2026 to holders of record on April 15, 2026. This marks a shift toward preserving flexibility in how Strategy funds its large Bitcoin treasury, including a very large US$42.10 billion at‑the‑market program...

Vontier Corporation recently entered into a 364-day senior unsecured term loan agreement for a US$300 million facility maturing on March 30, 2027, with interest tied to Term SOFR or a base rate plus ratings-based margins, to help repay 2026 senior unsecured notes and fund general corporate purposes. This short-term, unsecured financing underscores lenders’ confidence in Vontier’s credit profile while reshaping its near-term capital structure and liquidity position. We’ll now examine how...

Excelerate Energy (EE) is back in focus after officially naming and commissioning its newest floating storage and regasification unit, Excelerate Acadia, in South Korea. This highlights continued investment in LNG infrastructure capacity. See our latest analysis for Excelerate Energy. The share price has pulled back recently, with a 1 month share price return of 8.52% and a 7 day share price return of a 2.12% decline, even after a 90 day share price return of 15.56% and a 1 year total...

Why the TETON-1 IPF data matters for United Therapeutics (UTHR) United Therapeutics (UTHR) just reported positive Phase 3 TETON-1 results for nebulized Tyvaso in idiopathic pulmonary fibrosis, with meaningful lung function gains, fewer clinical worsening events, and no new safety concerns. The company now plans to seek FDA priority review to add IPF to Tyvaso’s label. This would target a large, underserved patient group and has quickly sharpened investor focus on UTHR’s growth story. See our...

Why Knowles matters for investors right now Knowles (KN) has quietly drawn attention after a strong past 3 months, with total return above 17%, while its latest figures show US$593.2 million in revenue and US$50.9 million in net income. See our latest analysis for Knowles. At a share price of US$25.87, Knowles has given investors a 17.86% year to date share price return and a 102.74% total shareholder return over the past year, pointing to firm positive momentum that contrasts with a modest 1...

Why Willis Lease Finance (WLFC) Is On Investors’ Radar Willis Lease Finance (WLFC) has drawn attention after a strong past 3 months total return of about 31%, alongside annual revenue of US$715.77m and net income of US$108.07m. See our latest analysis for Willis Lease Finance. The recent 4.4% 7-day share price return and current share price of US$175.89 follow a softer 30-day share price return of about a 5.3% decline. However, the 1-year total shareholder return of roughly 30.9% and very...

Pilgrim's Pride (PPC) is in focus after launching a cash tender offer for up to US$250 million of its 6.250% senior notes due 2033, alongside fresh shareholder proposals on political spending and diversity disclosures. See our latest analysis for Pilgrim's Pride. These debt and governance updates come after a mixed price stretch, with a 1 month share price return of an 8.39% decline and a 1 year total shareholder return of a 21.86% decline. However, the 3 year and 5 year total shareholder...

Yum! Brands recently appointed Kathleen (Leeny) K. Oberg, former Chief Financial Officer and Executive Vice President, Development of Marriott International, to its Board of Directors effective April 1, 2026, highlighting her extensive global finance and operations experience. By adding Oberg’s long-tenured hospitality and capital allocation background, Yum! Brands is signaling an emphasis on governance depth and disciplined growth oversight at the board level. We’ll now examine how bringing...

Vaxcyte (PCVX) recently reported full enrollment in its OPUS-1 and OPUS-2 Phase 3 trials for VAX-31, a key step toward a potential Biologics License Application that investors often monitor closely. See our latest analysis for Vaxcyte. The recent completion of enrollment in the OPUS-1 and OPUS-2 trials comes alongside strong momentum, with a 90 day share price return of 25.66% and a 1 year total shareholder return of 84.75%, while the latest share price stands at US$58.38. If this kind of...

In March 2026, Sun Communities’ audit committee replaced Grant Thornton with Deloitte & Touche as its independent auditor for the 2026 fiscal year, while analysts at Mizuho and BMO initiated or reiterated positive coverage highlighting the company’s manufactured housing and RV-focused business. Analysts also pointed to the potential sale of Sun’s UK Parks Holiday business and recent US$457 million of manufactured housing acquisitions as key ways to sharpen the company’s focus on core,...

FDA acceptance of bezuclastinib NDA puts Cogent Biosciences in focus Cogent Biosciences (COGT) is back on investors' radar after the FDA accepted its New Drug Application for bezuclastinib in Gastrointestinal Stromal Tumors under the Real-Time Oncology Review program. The filing follows results from the Phase 3 PEAK trial, in which bezuclastinib combined with sunitinib reduced the risk of disease progression or death by 50% compared with sunitinib alone and received Breakthrough Therapy...

Recently, billionaire investor Bill Ackman publicly described Federal Home Loan Mortgage Corporation (Freddie Mac) as a rare value opportunity, drawing fresh attention to the stock, while Freddie Mac’s latest survey showed the average 30-year fixed mortgage rate at 6.46% for top-tier borrowers. The combination of a high-profile endorsement and Freddie Mac’s role as a barometer of mortgage costs underscores how investor sentiment and housing finance conditions can intersect for this...